Moreover, this trial was conducted at a private practice and published in an alternative medicine journal, again raising concerns about bias
GLP-1: The Naturally Produced Hormone
This may involve reducing your semaglutide dose or getting maintenance doses
T1D Fund portfolio company i2O Therapeutics is developing several products leveraging GLP-1s, initially for T2D, including a refillable, implantable GLP-1 device that delivers 6 months worth of the hormone, an oral form of long acting GLP-1, as well as a combined oral GLP-1 with Amylin (another important pancreatic hormone)
Stop use and consult a healthcare provider if you experience severe allergic reactions (difficulty breathing, significant swelling, hives spreading beyond the injection site), chest pain or palpitations, severe or persistent gastrointestinal symptoms, or any symptom that concerns you significantly
doi: 10.3389/fmed.2024.1323091 31 LiF.WenX.XueP.XuH.WuP.XuZ.et al